日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genomic Profiling in Localized Prostate Cancer: Associations With Biochemical Recurrence and Response to Salvage Radiotherapy

局限性前列腺癌的基因组分析:与生化复发和挽救性放疗反应的关联

Zennami, Kenji; Takimoto, Tetsuya; Nukaya, Takuhisa; Sumitomo, Makoto; Takeda, Mayu; Sugihara, Eiji; Saya, Hideyuki; Shiroki, Ryoichi

Exposure to ileal feces with frailty-associated dysbiosis elevates gastrointestinal complication risk after intracorporeal urinary diversion

接触伴有虚弱相关菌群失调的回肠粪便会增加体内尿路改道术后胃肠道并发症的风险。

Zennami, Kenji; Nukaya, Takuhisa; Ishikawa, Kiyohito; Tomozawa, Shuhei; Kawai, Akihiro; Nakamura, Wataru; Muto, Yoshinari; Saruta, Masanobu; Motonaga, Tomonari; Takenaka, Masashi; Takahara, Kiyoshi; Kusaka, Mamoru; Sumitomo, Makoto; Shiroki, Ryoichi

Development and validation of nomograms for predicting pentafecta outcomes before and after robot-assisted radical prostatectomy: a retrospective study

机器人辅助根治性前列腺切除术前后五重结局预测列线图的建立与验证:一项回顾性研究

Bejrananda, Tanan; Takahara, Kiyoshi; Sowanthip, Dutsadee; Motonaga, Tomonari; Yagi, Kota; Nakamura, Wataru; Saruta, Masanobu; Nukaya, Takuhisa; Takenaka, Masashi; Zennami, Kenji; Ichino, Manabu; Sasaki, Hitomi; Sumitomo, Makoto; Shiroki, Ryoichi

Eosinophils as a predictive marker of treatment-related adverse events in mRCC patients treated with first-line immune-checkpoint inhibitor combination therapy

嗜酸性粒细胞作为一线免疫检查点抑制剂联合疗法治疗转移性肾细胞癌患者治疗相关不良事件的预测标志物

Kawada, Tatsushi; Katayama, Satoshi; Yanagisawa, Takafumi; Mori, Keiichiro; Fukuokaya, Wataru; Komura, Kazumasa; Tsujino, Takuya; Maenosono, Ryoichi; Takahara, Kiyoshi; Nukaya, Takuhisa; Inoki, Lan; Toyoda, Shingo; Hashimoto, Takeshi; Hirasawa, Yosuke; Edamura, Kohei; Kobayashi, Tomoko; Bekku, Kensuke; Nishimura, Shingo; Iwata, Takehiro; Sadahira, Takuya; Tominaga, Yusuke; Yamanoi, Tomoaki; Yoshinaga, Kasumi; Tsuboi, Kazuma; Kobayashi, Yasuyuki; Takamoto, Atsushi; Kurose, Kyohei; Kimura, Takahiro; Azuma, Haruhito; Shiroki, Ryoichi; Fujita, Kazutoshi; Ohno, Yoshio; Araki, Motoo

Biochemical recurrence prediction after robot-assited radical prostatectomy (BCR-PRARP)

机器人辅助根治性前列腺切除术后生化复发预测(BCR-PRARP)

Bejrananda, Tanan; Takahara, Kiyoshi; Sowanthip, Dutsadee; Motonaga, Tomonari; Yagi, Kota; Nakamura, Wataru; Saruta, Masanobu; Nukaya, Takuhisa; Takenaka, Masashi; Zennami, Kenji; Ichino, Manabu; Sasaki, Hitomi; Sumitomo, Makoto; Shiroki, Ryoichi

Evaluating antimicrobial effectiveness in acute uncomplicated cystitis: A retrospective single-center study

评估抗菌药物对急性单纯性膀胱炎的疗效:一项回顾性单中心研究

Nukaya, Takuhisa; Ishikawa, Kiyohito; Shiroki, Ryoichi

Role of Cytoreductive Nephrectomy in the Immune Checkpoint Inhibitor Era: A Multicenter Collaborative Study

细胞减灭性肾切除术在免疫检查点抑制剂时代的作用:一项多中心合作研究

Nukaya, Takuhisa; Takahara, Kiyoshi; Toyoda, Shingo; Inoki, Lan; Fukuokaya, Wataru; Mori, Keiichiro; Iwata, Takehiro; Bekku, Kensuke; Maenosono, Ryoichi; Tsujino, Takuya; Hirasawa, Yosuke; Yanagisawa, Takafumi; Hashimoto, Takeshi; Komura, Kazumasa; Araki, Motoo; Fujita, Kazutoshi; Ohno, Yoshio; Shiroki, Ryoichi

Impact of Estimated Glomerular Filtration Rate and Serum C-Reactive Protein Level to Overall Survival After Second-Line Targeted Therapy Following Immuno-Oncology Combination Therapy for Advanced Renal Cell Carcinoma

肾小球滤过率和血清C反应蛋白水平对晚期肾细胞癌患者接受免疫肿瘤联合治疗后二线靶向治疗后总生存期的影响

Nakane, Keita; Watanabe, Hiromitsu; Naiki, Taku; Takahara, Kiyoshi; Inamoto, Teruo; Yasui, Takahiro; Shiroki, Ryoichi; Miyake, Hideaki; Koie, Takuya

Cancer-induced Pain Is Associated With Poor Overall Survival of Urothelial Carcinoma Patients Treated With Enfortumab Vedotin

癌症引起的疼痛与接受恩福妥单抗治疗的尿路上皮癌患者的总体生存率较低相关。

Hashimoto, Mamoru; Fukiage, Ken; Taniguchi, Kosei; Minami, Takafumi; Yanagisawa, Takafumi; Fukuokaya, Wataru; Maenosono, Ryoichi; Yoshikawa, Yuki; Tsujino, Takuya; Saruta, Masanobu; Takahara, Kiyoshi; Hirasawa, Yosuke; Hashimoto, Takeshi; Ohno, Yoshio; Kimura, Takahiro; Shiroki, Ryoichi; Fujita, Kazutoshi

Upper urinary tract urothelial carcinoma patients show better overall response rate than bladder cancer patients during enfortumab vedotin treatment following pembrolizumab

在接受帕博利珠单抗治疗后,接受恩福妥单抗治疗的上尿路尿路上皮癌患者的总体缓解率优于膀胱癌患者。

Hashimoto, Mamoru; Fukiage, Ken; Taniguchi, Kosei; Minami, Takafumi; Fukuokaya, Wataru; Mori, Keiichiro; Yanagisawa, Takafumi; Tsujino, Takuya; Maenosono, Ryoichi; Saruta, Masanobu; Takahara, Kiyoshi; Hashimoto, Takeshi; Hirasawa, Yosuke; Azuma, Haruhito; Ohno, Yoshio; Shiroki, Ryoichi; Fujita, Kazutoshi